ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,901Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 783

$736K Total Retail Price of All Prescriptions

Rank: 119 out of 783

410 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 11,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
WARFARIN SODIUM 588 530 1 10
AMLODIPINE BESYLATE 512 467 2 5
FUROSEMIDE 480 457 3 7
SIMVASTATIN 457 412 4 3
LEVOTHYROXINE SODIUM 429 398 5 1
HYDROCODONE-ACETAMINOPHEN 368 313 S3 6 2
OMEPRAZOLE 343 311 7 6
LISINOPRIL 329 303 8 4
DONEPEZIL HCL 279 279 9 24
NAMENDA 247 235 10 32
METOPROLOL TARTRATE 229 204 11 9
PANTOPRAZOLE SODIUM 207 191 12 30
POTASSIUM CHLORIDE 165 149 13 16
GLIPIZIDE 165 147 13 71
CARVEDILOL 161 149 15 21
ESCITALOPRAM OXALATE 152 146 16 54
METFORMIN HCL 148 113 17 8
DIOVAN 148 135 17 49
ATORVASTATIN CALCIUM 146 132 19 11
KLOR-CON M10 141 141 20 137
METOPROLOL SUCCINATE 135 110 21 13
GABAPENTIN 134 119 22 15
CLOPIDOGREL 132 130 23 29
LIDODERM 129 126 24 132
LANTUS 120 109 25 38
POLYETHYLENE GLYCOL 3350 118 102 26 43
CRESTOR 115 108 27 27
LOSARTAN POTASSIUM 104 102 28 18
ZOLPIDEM TARTRATE 96 84 29 23
HYDROCHLOROTHIAZIDE 96 96 29 12
MIRTAZAPINE 91 86 31 52
CITALOPRAM HBR 91 90 31 19
ALLOPURINOL 88 87 33 31
HYDRALAZINE HCL 87 87 34 78
NOVOLIN R 87 68 34 185
FAMOTIDINE 86 78 36 55
KLOR-CON M20 86 84 36 48
OXYBUTYNIN CHLORIDE ER 85 85 38 117
RISPERIDONE 84 84 39 67
QUETIAPINE FUMARATE 81 74 40 79
ADVAIR DISKUS 81 72 40 50
DIGOXIN 78 78 42 61
AZITHROMYCIN 77 64 43 41
NYSTATIN 77 77 43 106
ATENOLOL 77 62 43 17
TRAMADOL HCL 76 76 46 20
TAMSULOSIN HCL 74 74 47 26
CLONIDINE HCL 70 57 48 60
GLIPIZIDE ER 69 62 49 84
PLAVIX 68 64 50 51
MELOXICAM 63 63 51 37
JANUVIA 62 60 52 73
PAROXETINE HCL 61 50 53 69
PROAIR HFA 58 46 54 56
LEVETIRACETAM 58 44 54 89
AMOX TR-POTASSIUM CLAVULANATE 58 55 54 128
SERTRALINE HCL 57 57 57 22
ENALAPRIL MALEATE 57 57 57 68
CIPROFLOXACIN HCL 55 53 59 62
SPIRIVA 54 40 60 59
LEVOFLOXACIN 54 50 60 75
TRAZODONE HCL 52 49 62 39
LEXAPRO 51 48 63 181
LAMOTRIGINE 50 48 64 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.